Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.
Takahashi T, Shigeyasu K, Kondo Y, Takeda S, Umeda H, Moriwake K, Kayano M, Sakurai Y, Nakamura S, Takahashi M, Nitta K, Yoshida K, Matsumi Y, Michiue H, Yamamoto H, Kishimoto H, Teraishi F, Shoji R, Kanaya N, Kashima H, Kakiuchi Y, Kuroda S, Kagawa S, Fujiwara T.
Takahashi T, et al. Among authors: takahashi m.
BMC Cancer. 2025 Jan 2;25(1):1. doi: 10.1186/s12885-024-13370-8.
BMC Cancer. 2025.
PMID: 39748254